3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Dermatologic
1
Conditions
Melanoma
350
Carcinoma, Non-Small-Cell Lung
81
Skin Neoplasms
72
Carcinoma, Renal Cell
51
Lung Neoplasms
50
Neoplasm Metastasis
47
Breast Neoplasms
46
Colorectal Neoplasms
45
Carcinoma, Basal Cell
43
Neoplasms
42
Uveal Melanoma
38
Squamous Cell Carcinoma of Head and Neck
37
Carcinoma, Merkel Cell
36
Ovarian Neoplasms
35
Sarcoma
32
Lymphoma, T-Cell, Cutaneous
31
Pancreatic Neoplasms
26
Prostatic Neoplasms
24
Carcinoma, Hepatocellular
23
Head and Neck Neoplasms
22
Stomach Neoplasms
21
Uterine Cervical Neoplasms
20
Urinary Bladder Neoplasms
20
Thyroid Neoplasms
20
Esophageal Neoplasms
19
Carcinoma, Squamous Cell
18
Brain Neoplasms
18
Carcinoma, Transitional Cell
17
Mycosis Fungoides
16
Triple Negative Breast Neoplasms
15
Interventions
vedolizumab
1
Photopheresis
1
Mycophenolic Acid
1
Methoxsalen
1
Infliximab
1
Azathioprine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hepatitis
×
Dermatologic
×
90 days
×
Clear all
NCT07619898
2026-06-02
PHOENIX-ECP
Therakos LLC
Phase 2
Not yet recruiting
112 enrolled